Table 2.
Total COPD | Symptomatic smokers | Asymptomatic smokers | |
GOLD I-III | GOLD 0 | ||
Biopsies, n | 19 | 8 | 24 |
CD3, %positive area | 1.05 (0.2–9.24) | 0.68 (0.19–1.7) | 0.76 (0.17–2.4) |
CD4, %positive area | 0.041 (0.01–0.57) | 0.073 (0–0.18) | 0.04 (0–0.15) |
CD8, %positive area | 0.27 (0.03–2.55) | 0.19 (0.02–1.53) | 0.33 (0.3–1.25) |
CD4/CD8 ratio | 0.19 (0.1–4.4) | 0.39 (0.04–1.2) | 0.18 (0–0.91) |
CD20, %positive area | 0.003 (0–3.40) | 0.003 (0–0.23) | 0.005 (0–0.12) |
NP57, %positive area | 0.025 (0–0.13) | 0.05 (0–0.23) | 0.021 (0–0.36) |
CD68, %positive area | 0.035 (0–0.21) | 0.056 (0–0.16) | 0.041 (0–0.32) |
EG2, %positive area | 0.021 (0–0.31) | 0.049 (0–0.15) | 0.063 (0–0.59) |
AA1, %positive area | 0.15 (0.01–0.91) | 0.22 (0–0.41) | 0.22 (0.1–1.16) |
Values expressed in median (range). Abbreviations: CD20 = B-cell marker, NP57 = neutrophil elastase, CD68 = macrophages, EG2 = eosinophils, AA1 = mast cell tryptase.